Optimal MRI sequence for evaluation of metabolism of 5-aminolevulinic acid (5-ALA)
Not Applicable
- Conditions
- malignant tumor
- Registration Number
- JPRN-UMIN000026091
- Lead Sponsor
- Tokyo Medical University
- Brief Summary
We performed this study in 4 cases, however, taget organ parathyroid could not be detect in MRI. Therfore, we stopped this study.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 15
Inclusion Criteria
Not provided
Exclusion Criteria
Presence of hypersensitivity for Porphyrin Presence of Porphyria Taking medicine as follows Tetracycline antibiotics Sulfonamide New quinolone antibacterial agent Hypericin Food containing horse millet
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Determination of optimal sequence for detecting the 5-ALA metabolism
- Secondary Outcome Measures
Name Time Method